from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun An experimental drug formerly being developed for the treatment of insomnia.


Sorry, no etymologies found.


  • In 2009, Sanofi-Aventis shelved its plan to develop eplivanserin, a serotonin antagonist.

    Dawn of A New Sleep Drug?

  • In some positive news for its R&D, Sanofi said its experimental insomnia treatment eplivanserin performed significantly better than a placebo pill in a large clinical trial.

    Sanofi-Aventis Profit Declines 14%

  • Nano drug ALX-0081 from Ablynx to open up blocked blood vessels coming Non opium pain drug tezampanel can treat acute migraine, says Raptor GlaxoSmithKline withdraws Zunrisa (casopitant) filings on safety fears Drug to improve cognition in Alzheimer's patients Lu AE58054 in human studies: Lundbeck US FDA seeks more data on Sanofi-Aventis sleep drug eplivanserin (Ciltyril)

    DWS Full News Feed

  • The US Food and Drug Administration or FDA, in September rejected eplivanserin, saying additional information about benefits and risks would be needed before approval.

    Latest News Articles

  • -- In September 2009, sanofi-aventis announced that it had received a Complete Response Letter from the FDA regarding eplivanserin



Log in or sign up to get involved in the conversation. It's quick and easy.